ARCHIVES

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995

Funding Opportunities: NKCA Offers Young Researcher Award

March 6, 1998

ASCO Members Pick Schilsky as President-Elect; Five Elected to Society’s Board of Directors.

February 16, 2007

Some Long-Term Survivors At Higher Risk Of Stroke

November 24, 2006

In Brief: HEW Opposes Research Contract Peer review; Congressman Blass Inadequate Grant Funds

May 10, 1974

Letters To the Editor: NCI director Broder responds To Kopans On Mammography

October 8, 1993